Melatonin is one of the most widely misused supplements in the world — not because it doesn't work, but because the standard commercial dose is roughly 10–20 times higher than the physiologically effective dose.
Understanding the pharmacology makes this clear. Getting the dose right significantly changes the cost-benefit ratio.
What melatonin is and what it does
Melatonin (N-acetyl-5-methoxytryptamine) is a hormone produced by the pineal gland from serotonin. It's the body's darkness signal — released in response to dim light after sunset, suppressed by blue-wavelength light.
Primary function: Circadian phase signal. Melatonin tells the body it's nighttime and shifts the circadian clock. It's a timing signal, not a sedative.
Secondary effects: Mild sleep-onset facilitation. Antioxidant properties (scavenges free radicals, though doses required may be pharmacological). Immune modulation.
What it's NOT: A sleep drug. It doesn't sedate in the way that zolpidem, benzodiazepines, or antihistamines do. It works by shifting circadian phase — which is why it's effective for jet lag but works differently from prescription sleep aids.
The dose the body actually produces
Endogenous peak melatonin production at night: 0.1–0.3mg (100–300 micrograms).
This is the concentration the body evolved to respond to. Melatonin receptors (MT1 and MT2) are saturated at low nanomolar concentrations.
Standard US supplement dose: 5–10mg.
That's 15–100× physiological levels.
What the research says about effective doses
Lewy et al. (2002, Journal of Clinical Endocrinology & Metabolism): Established that 0.5mg melatonin shifts circadian phase as effectively as 3mg in healthy adults. The dose-response curve plateaus at very low doses.
Dollins et al. (1994): 0.1–0.3mg melatonin reduced sleep onset latency similarly to higher doses. 10mg produced more physiological changes but not better sleep outcomes.
Zhdanova et al. (1995, 1996): 0.3mg melatonin reduced sleep onset latency and improved sleep quality comparably to 1mg and higher.
MIT Technology Review (citing Wurtman, MIT, 2001): Richard Wurtman — one of the scientists who developed melatonin supplementation — explicitly stated that the doses sold commercially (3–10mg) are pharmacological, not physiological, and may cause receptor downregulation.
Conclusion from the research: 0.5mg is the evidence-based dose for most applications. 1mg covers most individual variation. 3mg is the upper range of justified dosing. 10mg has no established benefit over 0.5mg and accumulates risks.
Why commercial products are 10–20× overdosed
- Regulatory framework: In the US, melatonin is classified as a dietary supplement, not a hormone or drug. FDA doesn't regulate dosing.
- Manufacturing economics: Higher doses allow "premium" pricing with minor incremental cost.
- Consumer perception: "More = more effective" is a universal supplement marketing bias.
- Competition: Once 5mg became standard, competitors matched or exceeded it.
In most of Europe and the UK, melatonin is a prescription medication with regulated dosing (typically 0.5–2mg). This reflects the pharmacological reality better than the US supplement market.
Risks of overdosing melatonin
Morning grogginess
High-dose melatonin has a longer effective duration than the ~4–6 hour nighttime window. 10mg melatonin taken at bedtime maintains elevated levels into the morning, causing grogginess and cognitive impairment.
This is the most common complaint — people notice they feel groggy the next day and conclude melatonin doesn't work for them. The correct response is to lower the dose, not stop taking it.
Receptor downregulation
Chronic pharmacological melatonin exposure may downregulate MT1/MT2 receptors, reducing sensitivity to endogenous melatonin and potentially worsening natural sleep architecture over time.
This is well-documented for pharmacological receptors generally; specific human data on melatonin receptor downregulation from supplement doses is limited but mechanistically concerning.
Hormonal effects in children
Melatonin interacts with the hypothalamic-pituitary axis. High-dose chronic use in children and adolescents has raised concerns about reproductive hormone development. Most pediatric sleep medicine guidelines recommend doses of 0.5–1mg maximum, time-limited, under medical supervision.
Interaction with the immune system
Melatonin has significant immune-modulatory effects at pharmacological doses. Unclear implications for people with autoimmune conditions or on immunosuppressants.
The right applications for melatonin
Jet lag — strongest evidence:
Melatonin is most effective for resetting circadian phase across time zones. Takahashi et al. and Arendt et al. established this clearly. Protocol: 0.5mg taken at bedtime at the destination for 3–5 days. Highly effective.
Delayed sleep phase (night owls):
0.5mg taken 5–6 hours before desired sleep onset gradually shifts the circadian clock earlier. Requires consistency over 1–2 weeks.
Shift workers:
Helps reset circadian phase when rotating schedules require sleeping at non-standard times.
General sleep onset (insomnia):
More modest evidence. Works best for people with circadian delay (trouble falling asleep, not staying asleep). 0.5mg taken 30–60 minutes before target bedtime. Not effective for sleep maintenance insomnia.
Timing matters as much as dose
Melatonin's effect is timing-dependent:
- Too early (6+ hours before sleep): Can cause daytime drowsiness and phase shifts in wrong direction
- At bedtime: Standard application for sleep onset
- For jet lag: Match to destination bedtime from day 1 of travel
Taking melatonin at random times without circadian consideration is why many people report it "doesn't work."
Formulation: immediate vs. extended release
Immediate release: Standard form. Produces a peak and drops — mimics the natural melatonin pulse. Best for sleep onset and jet lag.
Extended release: Maintains levels through the night. May help sleep maintenance (staying asleep). Less studied than immediate release. May contribute to morning grogginess.
Liquid/sublingual: Faster absorption. Useful for precise timing.
Practical protocol
General sleep onset support:
- 0.5mg immediate release, 30–60 min before target bedtime
- Light control (dim lights, blue-blocking glasses) remains more important than melatonin dose
Jet lag:
- 0.5mg at target destination bedtime from day 1 of travel
- Continue 3–5 nights
- Eastward travel: take earlier each day. Westward: later.
Shift work:
- 0.5mg 30 min before sleep during shifted schedule
- Return to no melatonin when on regular schedule
What to avoid:
- More than 1mg as a starting dose
- Chronic daily use without a break (use situationally)
- Use in children without medical guidance
- Combination with sedatives, antidepressants, or immunosuppressants without checking interactions
The framework applied
For any melatonin study:
- What dose? 0.5mg and 10mg studies are not comparable — dose-response is not linear.
- What application? Jet lag vs. insomnia vs. shift work vs. sleep quality in healthy adults — different populations, different evidence.
- What timing? Melatonin at wrong circadian time can shift phase in undesired direction.
- Immediate or extended release? Different pharmacokinetics, different applications.
We automated this at Q-SCI. Any study — paste it, get a quality score.
Bottom line
- 0.5mg is the evidence-based starting dose — equally effective as 5–10mg for circadian effects, with fewer side effects
- Physiological melatonin production is 0.1–0.3mg; 10mg commercial tablets are ~30–100× physiological levels
- Morning grogginess from standard doses is the most common misuse symptom — fix it by lowering the dose, not stopping
- Strongest evidence: jet lag correction and delayed sleep phase disorder
- Moderate evidence: sleep onset in circadian delay; weaker evidence for sleep maintenance
- Use situationally — jet lag, shift work, occasional sleep onset difficulty — not as a nightly indefinite supplement
- Children: maximum 0.5–1mg under medical guidance only
Buy 0.5mg or 1mg tablets. Ignore the 10mg aisle.
More evidence-based analyses at q-sci.org/blog. Score studies free at q-sci.org.
Top comments (0)